Cargando…
Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most intractable malignancy, with an only 6% 5-year relative survival rate. The dismal therapeutic effect is attributed to the chemotherapy resistance and unique pathophysiology with abundant inflammatory cytokines and abnormal hyperplasia of ext...
Autores principales: | Zhou, Yu, Zhou, Wenxi, Chen, Xinli, Wang, Qingbing, Li, Chao, Chen, Qinjun, Zhang, Yu, Lu, Yifei, Ding, Xiaoyi, Jiang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488356/ https://www.ncbi.nlm.nih.gov/pubmed/32963950 http://dx.doi.org/10.1016/j.apsb.2019.11.013 |
Ejemplares similares
-
Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy
por: He, Xi, et al.
Publicado: (2018) -
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
por: Chen, Qinjun, et al.
Publicado: (2019) -
GLUT1-mediated effective anti-miRNA21 pompon for cancer therapy
por: Guo, Qin, et al.
Publicado: (2019) -
Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation
por: Chen, Qinjun, et al.
Publicado: (2020) -
Promising Therapeutic Functions of Bone Marrow Mesenchymal Stem Cells Derived-Exosome in Asthma
por: Yuan, Jia-Ying, et al.
Publicado: (2022)